• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 25-11-2025: Press Release

    25-11-2025 | 03:54 pm

    Zydus Lifesciences received USFDA approval for Verapamil Hydrochloride Extended-Release Tablets, a drug for high blood pressure. This product recorded annual US sales of USD 24.5 million and will be produced at Zydus' Baddi plant.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited